Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (63 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026



Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF | V.TLT.W

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Justice Served ! Singer to pay Theralase $35,000.
View:
Post by Oden6570 on Apr 07, 2021 7:59am

Justice Served ! Singer to pay Theralase $35,000.

Comment by Pandora on Apr 07, 2021 10:00am
Too bad it doesn't get added to the revenue line. It might help.:-)
Comment by woundedknee on Apr 07, 2021 1:12pm
I forget what Roger's penalty was for misleading investors. Wasn't he banned from trading for five years and I forget if he was fined or not.
Comment by Yajne on Apr 07, 2021 10:45pm
so wounded, were you the little fella that turned on Roger? Seems you are one of very few who still have that event on their mind....just sayin. Nice attempt at a not-so-soft bash though!
Comment by Longholder99 on Apr 08, 2021 8:11am
Ive had that handle on ignore for months. The list gets long but i suspect we are dealing with one...maybe two actual bashers here.
Comment by woundedknee on Apr 08, 2021 8:39am
Nothing at all to do with bashing. Just saying it like it is. Roger "overpromoted"  the cold laser device and got his hand slapped. This guy said TLT was a pump and dump and got punished as well. TLT got 35k. So where did that money go? Just trying to compare the two. Sometimes you have to wonder why this stock has lanquished for so many years. Bencro use to say(paraphrasing) forget ...more  
Comment by TriumphSpitSix on Apr 08, 2021 10:37pm
Trying to keep the sheep in line with the parable of an idiot who used a traceable email? Pffft.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 63 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     


Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250